IDO1 and cancer: Hence, amino acid-degrading enzymes that are substantially increased in cancer are of particular interest, i.e., indoleamine 2,3-dioxygenase 1 (IDO)-degrading l-tryptophan and arginases hydrolysing l-arginine [7].